Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2)

The cancer-associated protein Anterior Gradient 2 (AGR2) has been described, predominantly in adenocarcinomas. Increased levels of extracellular AGR2 (eAGR2) have been correlated with poor prognosis in cancer patients, making it a potential biomarker. Additionally, neutralizing AGR2 antibodies showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Garri, Carolina, Howell, Shannon, Tiemann, Katrin, Tiffany, Aleczandria, Jalali-Yazdi, Farzad, Alba, Mario M., Katz, Jonathan E., Takahashi, Terry T., Landgraf, Ralf, Gross, Mitchell E., Roberts, Richard W., Kani, Kian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007958/
https://www.ncbi.nlm.nih.gov/pubmed/29937991
http://dx.doi.org/10.18632/oncotarget.25221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007958/
https://www.ncbi.nlm.nih.gov/pubmed/29937991
http://dx.doi.org/10.18632/oncotarget.25221

Ejemplares similares